Synercid® | |
Brand Name: | Synercid® |
Active Ingredient: | quinupristin/dalfopristin |
Strength(s): | 500 mg (150mg of quinupristin and 350mg of dalfopristin) |
Dosage Form(s): | Powder for injection |
Company Name: | Rhone-Poulenc Rorer |
Availability: | Prescription only |
*Date Approved by the FDA: | September 21, 1999 |
*Approval by FDA does not mean that the drug is available for consumers at this time. |
What is Synercid used for? Synercid is used to treat adult patients with serious or life-threatening infections and certain skin infections caused by specific types of bacteria. Synercid was approved based on its ability to clear bacteria from the bloodstream. At this time, it is not known if Synercid will cure the underlying infection. Clinical studies to determine Synercids ability to cure underlying infection are presently under way. Special Warnings with Synercid:
General Precautions with Synercid:
How is Synercid given? Synercid is given by IV in a hospital setting. What are some possible side effects of Synercid? (This is NOT a complete list of side effects reported with Synercid. Your health care provider can discuss with you a more complete list of side effects.)
For more detailed information about Synercid, ask your health care provider. 5/23/00 |